President Trump’s executive order provides a framework for tying the prices of U.S. pharmaceutical products to the lower ...

Americans’ trust in the overall healthcare system is dwindling — but experts believe it can be rebuilt. Public trust in the U.S. healthcare system fell from 71.5% in 2020 to 40.1% in 2024 ...

For the past couple of years, clinicians have been singing the praises of generative AI-powered clinical documentation tools, saying that these models give them hours back into their day.

Social determinants of health (SDOH) screening tools have been prioritized in emerging healthcare delivery models aimed at transforming traditional care delivery and reimbursing a broader bench of ...

Organizations across the entire healthcare ecosystem have been betting big on AI. The excitement is justified. Implementing these technologies can save a lot of time and money to do a lot of ...

Withings Health Solutions and Babyscripts announced a partnership Thursday that aims to address hypertensive disorders of pregnancy, which are among the leading causes of maternal mortality.

On Wednesday, Cedars-Sinai and Redesign Health launched a new innovation center that seeks to build digital health startups from the ground up. Los Angeles-based Cedars-Sinai comprises more than ...

Many drugs available and in development work by targeting proteins, an approach that comes with limitations. For one, proteins are not the root cause of disease, said Samir Ounzain, co-founder and ...

Innovative marketing practices are the goal of every marketer; however, sometimes, it’s essential to consider not what new marketing tactic will be influential but how you can leverage existing ...

Representative clinical studies are important as diseases and medicines can affect people differently depending on their age, sex, and race and ethnicity. According to the Food and Drug ...

The health care industry is a critical sector that helps save people’s lives. Sometimes, medical professionals and patients have communication barriers that can hinder that process. However, the ...

A rare type of ovarian cancer that grows slowly and responds poorly to chemotherapy now has its first FDA-approved treatment, a combination drug developed by Verastem Oncology to address a pathway ...